Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Journal of Parkinson'S Disease and Alzheimer'S Disease|March 5, 2016
Alternative Splicing in Alzheimer's DiseaseJulia E Love, Eric J Hayden, Troy T RohnJournal of Parkinson'S Disease and Alzheimer'S Disease|January 17, 2015
Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?Troy T Rohn, Katie L McCarty, Julia E Love, et al.Brain Research|July 19, 2008
Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's diseaseTroy T RohnOxidative Medicine and Cellular Longevity|March 28, 2013
The triggering receptor expressed on myeloid cells 2: "TREM-ming" the inflammatory component associated with Alzheimer's diseaseTroy T RohnInternational Journal of Molecular Sciences|July 23, 2013
Proteolytic cleavage of apolipoprotein E4 as the keystone for the heightened risk associated with Alzheimer's diseaseTroy T RohnApoptosis : an International Journal on Programmed Cell Death|February 4, 2010
The role of caspases in Alzheimer's disease; potential novel therapeutic opportunitiesTroy T RohnHistology and Histopathology|June 26, 2009
Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspasesTroy T RohnInternational Journal of Neurology and Neurotherapy|November 10, 2015
Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?Troy T RohnInternational Journal of Clinical and Experimental Pathology|August 15, 2014
Is apolipoprotein E4 an important risk factor for vascular dementia?Troy T RohnCNS & Neurological Disorders Drug Targets|April 10, 2012
Targeting alpha-synuclein for the treatment of Parkinson's diseaseTroy T RohnPageof 9